Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
- Status
- RECRUITING
- Phase
- PHASE2
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Treatment of Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
- Status
- SUSPENDED
- Phase
- PHASE2
ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2
FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2